Khaled Matrawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khaled Matrawy has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Adel Ibrahim Hozien
Department of Anesthesia and Pain Management, Medical Research Institute, Alexandria University, Alexandria, Egypt
1 shared publication - Adel Shalabi
Department of Radiology, Institution of Surgical Sciences, Akademiska Hospital, Uppsala University, Uppsala, Sweden
1 shared publication - Ahmed Mostafa Kassem
Diagnostic and Interventional Radiology Department, Port Said University, Port Said, Egypt
1 shared publication - Ahmed Samir
Department of Radio-diagnosis, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
1 shared publication - Anwar Ashraf Abouelnasr
Department of Surgery, Medical Research Institute, Alexandria University, Alexandria, Egypt
1 shared publication - Asmaa Hamdy
Alexandria University, Alexandria, Egypt
1 shared publication
Latest Publications
- Open Access
- 13 November 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5316-5335
Anatomical Remodeling of the Upper Airway after Laparoscopic Sleeve Gastrectomy: A Multimodal Assessment of Structural and Functional Improvements in Obstructive Sleep Apnea
Introduction: Obstructive Sleep Apnea (OSA) represents a significant global health challenge, closely linked to obesity and a heightened risk for cardiovascular and metabolic disorders. Continuous Positive Airway Pressure (CPAP) remains the cornerstone of OSA management; however, its effectiveness is often hindered by patient adherence and tolerance. Metabolic and bariatric surgery (MBS) has emerged as a viable alternative by reducing excess weight and improving upper airway anatomy. Among the various MBS techniques, Sleeve Gastrectomy (SG) has gained prominence due to its favorable outcomes and limited complications. This study aims to assess the impact of SG on OSA, utilizing Magnetic Resonance Imaging (MRI) and polysomnography to analyze structural changes and clinical outcomes. Methods: In this prospective study, 40 participants aged 18–65 years with a BMI exceeding 30 kg/m² and a confirmed diagnosis of OSA (apnea-hypopnea index [AHI] ≥ 5) were enrolled. Pre- and post-operative evaluations included an MRI of the upper airway, polysomnography, and the Epworth Sleepiness Scale (ESS) to quantify daytime somnolence. Statistical analysis was conducted using Generalized Estimating Equations (GEE) and correlation tests in R software, focusing on changes in weight, BMI, AHI, Oxygen Desaturation Index (ODI), and airway dimensions. Results: Post-SG, participants exhibited significant weight reduction, averaging − 43.8 kg ( p < 0.001), and a decrease in BMI of -15.7 kg/m² ( p < 0.001). Both AHI and ODI demonstrated significant declines ( p < 0.001), with daytime sleepiness normalizing in all subjects. MRI analysis indicated notable increases in upper airway dimensions coupled with a reduction in tongue volume. Additionally, CPAP reliance decreased from 90% to 22.5%. Remarkably, diabetes and hypertension were resolved in all subjects. Conclusion: This study suggests that SG may yield 12-month improvements in OSA severity, upper airway structure, and CPAP dependency in patients with obesity. The findings highlight SG as a potentially valuable adjunct treatment, although larger, long-term studies are warranted to confirm these results and inform clinical decision-making.
- 13 November 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5316-5335
Open AccessAnatomical Remodeling of the Upper Airway after Laparoscopic Sleeve Gastrectomy: A Multimodal Assessment of Structural and Functional Improvements in Obstructive Sleep Apnea
Introduction: Obstructive Sleep Apnea (OSA) represents a significant global health challenge, closely linked to obesity and a heightened risk for cardiovascular and metabolic disorders. Continuous Positive Airway Pressure (CPAP) remains the cornerstone of OSA management; however, its effectiveness is often hindered by patient adherence and tolerance. Metabolic and bariatric surgery (MBS) has emerged as a viable alternative by reducing excess weight and improving upper airway anatomy. Among the various MBS techniques, Sleeve Gastrectomy (SG) has gained prominence due to its favorable outcomes and limited complications. This study aims to assess the impact of SG on OSA, utilizing Magnetic Resonance Imaging (MRI) and polysomnography to analyze structural changes and clinical outcomes. Methods: In this prospective study, 40 participants aged 18–65 years with a BMI exceeding 30 kg/m² and a confirmed diagnosis of OSA (apnea-hypopnea index [AHI] ≥ 5) were enrolled. Pre- and post-operative evaluations included an MRI of the upper airway, polysomnography, and the Epworth Sleepiness Scale (ESS) to quantify daytime somnolence. Statistical analysis was conducted using Generalized Estimating Equations (GEE) and correlation tests in R software, focusing on changes in weight, BMI, AHI, Oxygen Desaturation Index (ODI), and airway dimensions. Results: Post-SG, participants exhibited significant weight reduction, averaging − 43.8 kg ( p < 0.001), and a decrease in BMI of -15.7 kg/m² ( p < 0.001). Both AHI and ODI demonstrated significant declines ( p < 0.001), with daytime sleepiness normalizing in all subjects. MRI analysis indicated notable increases in upper airway dimensions coupled with a reduction in tongue volume. Additionally, CPAP reliance decreased from 90% to 22.5%. Remarkably, diabetes and hypertension were resolved in all subjects. Conclusion: This study suggests that SG may yield 12-month improvements in OSA severity, upper airway structure, and CPAP dependency in patients with obesity. The findings highlight SG as a potentially valuable adjunct treatment, although larger, long-term studies are warranted to confirm these results and inform clinical decision-making.
- Open Access
- 19 May 2022
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 53 (1) , 1-14
Splenomegaly versus pathological lung volume during COVID-19 infection with or without cytokine storm; a linear regression analysis using CT volumetry
Background: Due to the paucity of scientific evidence, it is unclear among pulmonologists and physicians in critical care units if and when splenomegaly in novel coronavirus disease (2019) (COVID-19) patients is worrisome. This study aims to evaluate the significance of splenic volume during COVID-19 infection with or without cytokine storm and correlates splenic volume to the volume of pathological lung changes through linear regression analysis. Results: A retrospective study collected 509 polymerase chain reaction proved COVID-19 patients (399 males, 110 females; mean age 48 years, age range 24–78 years) between June and November 2021, without a history of splenic pathology. A control group of age and sex-matched 509 healthy subjects was used and analyzed according to the splenic volume. Five consulting radiologists evaluated initial and follow-up computed tomography (CT) examinations using lung CT volumetry and splenic volume calculation in consensus. Three consulting pulmonologists correlated the severity of clinical and laboratory findings, including oxygen requirements and interleukin-6 (IL-6) levels. The T test results for comparison between the COVID-19 patients and the healthy subjects control group regarding the splenic volume were significant (T value was − 4.731452 and p value was 0.00002). There was no significant correlation between the severity of the disease and normal-sized spleen (26% of patients, p = 0.916) or splenomegaly (24% of patients, p = 0.579). On the other hand, all patients with a small spleen or progressive splenomegaly during serial follow-up imaging had clinically severe disease with a statistically significant correlation (p = 0.017 and 0.003, respectively). Ninety-seven percent of patients with clinically mild disease and splenomegaly had 0–20% lung involvement (CT-severity score 1) while all patients with clinically severe disease and splenomegaly had 27–73% lung involvement (CT-severity score 2 and 3) (r = 0.305, p = 0.030). Conclusions: Splenomegaly is a non-specific sign that may be found during mild and severe COVID-19 infection, it was not statistically correlated with the clinical severity and a weak positive relationship was found between the splenic size and the CT-severity score of the pathological lung volume. On the other hand, the presence of splenic atrophy or progressive splenomegaly was correlated with severe COVID-19 presentation and “cytokine storm”. Therefore, the splenic volume changes should not be overlooked in COVID-19 serial CT examinations, particularly in severe or critically ill patients with cytokine storms.
- 19 May 2022
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 53 (1) , 1-14
Open AccessSplenomegaly versus pathological lung volume during COVID-19 infection with or without cytokine storm; a linear regression analysis using CT volumetry
Background: Due to the paucity of scientific evidence, it is unclear among pulmonologists and physicians in critical care units if and when splenomegaly in novel coronavirus disease (2019) (COVID-19) patients is worrisome. This study aims to evaluate the significance of splenic volume during COVID-19 infection with or without cytokine storm and correlates splenic volume to the volume of pathological lung changes through linear regression analysis. Results: A retrospective study collected 509 polymerase chain reaction proved COVID-19 patients (399 males, 110 females; mean age 48 years, age range 24–78 years) between June and November 2021, without a history of splenic pathology. A control group of age and sex-matched 509 healthy subjects was used and analyzed according to the splenic volume. Five consulting radiologists evaluated initial and follow-up computed tomography (CT) examinations using lung CT volumetry and splenic volume calculation in consensus. Three consulting pulmonologists correlated the severity of clinical and laboratory findings, including oxygen requirements and interleukin-6 (IL-6) levels. The T test results for comparison between the COVID-19 patients and the healthy subjects control group regarding the splenic volume were significant (T value was − 4.731452 and p value was 0.00002). There was no significant correlation between the severity of the disease and normal-sized spleen (26% of patients, p = 0.916) or splenomegaly (24% of patients, p = 0.579). On the other hand, all patients with a small spleen or progressive splenomegaly during serial follow-up imaging had clinically severe disease with a statistically significant correlation (p = 0.017 and 0.003, respectively). Ninety-seven percent of patients with clinically mild disease and splenomegaly had 0–20% lung involvement (CT-severity score 1) while all patients with clinically severe disease and splenomegaly had 27–73% lung involvement (CT-severity score 2 and 3) (r = 0.305, p = 0.030). Conclusions: Splenomegaly is a non-specific sign that may be found during mild and severe COVID-19 infection, it was not statistically correlated with the clinical severity and a weak positive relationship was found between the splenic size and the CT-severity score of the pathological lung volume. On the other hand, the presence of splenic atrophy or progressive splenomegaly was correlated with severe COVID-19 presentation and “cytokine storm”. Therefore, the splenic volume changes should not be overlooked in COVID-19 serial CT examinations, particularly in severe or critically ill patients with cytokine storms.
- Open Access
- 1 October 2013
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 14 (4) , 337-352
Association of serum fetuin-A and fetuin-A gene polymorphism in relation to mineral and bone disorders in patients with chronic kidney disease
- 1 October 2013
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 14 (4) , 337-352
Open AccessAssociation of serum fetuin-A and fetuin-A gene polymorphism in relation to mineral and bone disorders in patients with chronic kidney disease
- Open Access
- 31 December 2011
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 42 (3-4) , 351-356
Primary sclerosing cholangitis: Evaluation with MR cholangiopancreatography (MRCP)
- 31 December 2011
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 42 (3-4) , 351-356
Open AccessPrimary sclerosing cholangitis: Evaluation with MR cholangiopancreatography (MRCP)